NEOS insider filings

Neos Therapeutics, Inc. — 13 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-03-19. Screen NEOS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for NEOS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Neos Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2021-03-194Robinson James A. Jr. — DirectorDisposition to issuer (D): 23,453 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0EDGAR
2021-03-194McLaughlin Gerald W. — Chief Executive Officer, DirectorDisposition to issuer (D): 270,171 · Disposition to issuer (D): 600,000 (derivative) @ $0 · Disposition to issuer (D): 392,688 (derivative) @ $0 · Disposition to issuer (D): 395,000 (derivative) @ $0 · Disposition to issuer (D): 100,000 (derivative) @ $0 · Disposition to issuer (D): 65,447 (derivative) @ $0EDGAR
2021-03-194Hecht Beth — DirectorDisposition to issuer (D): 23,453 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 14,777 (derivative) @ $0 · Disposition to issuer (D): 18,322 (derivative) @ $0 · Disposition to issuer (D): 22,756 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0EDGAR
2021-03-194Schmid John P. — DirectorDisposition to issuer (D): 23,453 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 14,777 (derivative) @ $0 · Disposition to issuer (D): 18,322 (derivative) @ $0 · Disposition to issuer (D): 22,756 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0EDGAR
2021-03-194Fong Bryant — DirectorDisposition to issuer (D): 24,953 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 14,777 (derivative) @ $0 · Disposition to issuer (D): 18,322 (derivative) @ $0 · Disposition to issuer (D): 22,756 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0EDGAR
2021-03-194Szyper Linda M — DirectorDisposition to issuer (D): 23,453 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 22,756 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0EDGAR
2021-03-194Eisenstadt Richard I — Chief Financial OfficerDisposition to issuer (D): 126,245 · Disposition to issuer (D): 86,167 (derivative) @ $0 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 60,230 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 45,000 (derivative) @ $0 · +3 moreEDGAR
2021-03-194Limongelli John M — SVP & General CounselDisposition to issuer (D): 83,015 · Disposition to issuer (D): 150,000 (derivative) @ $0 · Disposition to issuer (D): 115,000 (derivative) @ $0EDGAR
2021-03-194ROBITAILLE GREGORY J — DirectorDisposition to issuer (D): 79,130 · Disposition to issuer (D): 10,416 (derivative) @ $0 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 14,777 (derivative) @ $0 · Disposition to issuer (D): 18,322 (derivative) @ $0 · Disposition to issuer (D): 22,756 (derivative) @ $0 · +1 moreEDGAR
2021-03-194HELLER ALAN L — DirectorDisposition to issuer (D): 446,819 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 14,777 (derivative) @ $0 · Disposition to issuer (D): 18,322 (derivative) @ $0 · Disposition to issuer (D): 22,756 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0EDGAR
2021-03-164McLaughlin Gerald W. — Chief Executive Officer, DirectorTax withholding (F): 44,329 @ $0.84EDGAR
2021-03-164Eisenstadt Richard I — Chief Financial OfficerTax withholding (F): 1,390 @ $0.88 · Tax withholding (F): 14,825 @ $0.84EDGAR
2021-03-164Limongelli John M — SVP & General CounselTax withholding (F): 16,985 @ $0.84EDGAR

Recent 8-K events — Neos Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-03-228-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2021-02-088-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2021-01-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2020-12-308-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2020-12-118-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2020-12-108-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2020-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2020-08-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NEOS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs